Covered recipient · General Payments record
BRANDY A GLORIOSO
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant Medical
General Payments · PY2021–2024
$2,636.87
- Reported across 47 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,462.96 | 31 |
| Travel and Lodging | $792.62 | 3 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| BOSTON SCIENTIFIC CORPORATION | $1,035.54 | 7 |
| Nevro Corp. | $830.86 | 22 |
| Averitas Pharma Inc. | $146.28 | 1 |
| MML US, Inc. | $140.23 | 1 |
| Abbott Laboratories | $55.99 | 1 |
| Saluda Medical Americas, Inc. | $29.19 | 1 |
| PAINTEQ LLC | $17.49 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (34)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $55.99 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125053569 | CMS |
| Averitas Pharma Inc. | $146.28 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133458790 | CMS |
| Boston Scientific Corporation | $20.52 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092583879 | CMS |
| Boston Scientific Corporation | $62.57 | 04/26/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1092583883 | CMS |
| Boston Scientific Corporation | $350.09 | 04/26/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1092583887 | CMS |
| Boston Scientific Corporation | $379.96 | 04/26/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1092583889 | CMS |
| Boston Scientific Corporation | $171.63 | 04/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092583885 | CMS |
| Boston Scientific Corporation | $37.34 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092583881 | CMS |
| Boston Scientific Corporation | $13.43 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092583877 | CMS |
| MML US, Inc. | $140.23 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152304653 | CMS |
| Nevro Corp. | $6.81 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130745210 | CMS |
| Nevro Corp. | $7.54 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130745228 | CMS |
| Nevro Corp. | $5.60 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130745306 | CMS |
| Nevro Corp. | $127.95 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130745242 | CMS |
| Nevro Corp. | $9.48 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130745308 | CMS |
| Nevro Corp. | $13.64 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130745354 | CMS |
| Nevro Corp. | $41.87 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130745224 | CMS |
| Nevro Corp. | $141.19 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130745226 | CMS |
| Nevro Corp. | $6.99 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130745300 | CMS |
| Nevro Corp. | $5.50 | 06/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130745352 | CMS |
| Nevro Corp. | $6.99 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130745302 | CMS |
| Nevro Corp. | $6.60 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130745316 | CMS |
| Nevro Corp. | $7.23 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130745218 | CMS |
| Nevro Corp. | $132.42 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130745304 | CMS |
| Nevro Corp. | $105.82 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130745220 | CMS |
| Nevro Corp. | $36.76 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130745222 | CMS |
| Nevro Corp. | $37.93 | 09/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130745312 | CMS |
| Nevro Corp. | $9.57 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130745212 | CMS |
| Nevro Corp. | $76.00 | 11/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130745214 | CMS |
| Nevro Corp. | $27.27 | 11/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130745216 | CMS |
| Nevro Corp. | $8.48 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130745310 | CMS |
| Nevro Corp. | $9.22 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130745314 | CMS |
| PAINTEQ LLC | $17.49 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142007211 | CMS |
| Saluda Medical Americas, Inc. | $29.19 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1093674072 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.